The global impact of vaccines containing aluminium adjuvants.

[1]  C. J. Clements,et al.  Vaccine safety concerns everyone. , 1999, Vaccine.

[2]  G. Giammanco,et al.  Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules , 1998 .

[3]  P. van Damme,et al.  Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system. , 1998, Vaccine.

[4]  F. Vogel,et al.  Adjuvants in perspective. , 1998, Developments in biological standardization.

[5]  R. Gupta,et al.  Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. , 1998, Developments in biological standardization.

[6]  Robert T. Chen,et al.  The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. , 1997, American journal of public health.

[7]  G. Leroux-Roels,et al.  Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults. , 1997, Vaccine.

[8]  J. Cherry,et al.  Historical review of pertussis and the classical vaccine. , 1996, The Journal of infectious diseases.

[9]  H. Margolis,et al.  Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age. , 1996, The Pediatric infectious disease journal.

[10]  J. English,et al.  Anaphylaxis after hepatitis B vaccination , 1995, The Lancet.

[11]  R. Johnston,et al.  Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , 1994 .

[12]  R. Johnston,et al.  EVIDENCE BEARING ON CAUSALITY , 1994 .

[13]  L. Mitchell,et al.  Role of whole-cell pertussis vaccine in severe local reactions to the preschool (fifth) dose of diphtheria-pertussis-tetanus vaccine. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[14]  S. Medendorp,et al.  Comparative study of the immunogenicity and safety of two dosing schedules of Engerix-B hepatitis B vaccine in neonates. , 1994, The Pediatric infectious disease journal.

[15]  A. Theamboonlers,et al.  Randomized, single-blind comparison of the immunogenicity and reactogenicity of 20 micrograms and 10 micrograms doses of hepatitis B vaccine in adolescents. , 1993, The Southeast Asian journal of tropical medicine and public health.

[16]  Rajesh K. Gupta,et al.  Adjuvants--a balance between toxicity and adjuvanticity. , 1993, Vaccine.

[17]  B. McMahon,et al.  Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. , 1992, The American journal of medicine.

[18]  R. Gupta,et al.  Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine. , 1991, Vaccine.

[19]  J Huchet,et al.  Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens. , 1991, Vaccine.

[20]  Gary J. Nabel,et al.  New Generation Vaccines , 1990 .

[21]  K. Tan,et al.  Immunogenicity and Safety of Low Doses of Recombinant Yeast‐Derived Hepatitis B Vaccine , 1990, Acta paediatrica Scandinavica.

[22]  S. Wassilak,et al.  Longitudinal study of adverse reactions following diphtheria-tetanus-pertussis vaccine in infancy. , 1990, Pediatrics.

[23]  L. Andrén.  General considerations in selecting antihypertensive agents in patients with type II diabetes mellitus and hypertension. , 1989, The American journal of medicine.

[24]  W. Orenstein,et al.  Family history of convulsions and use of pertussis vaccine. , 1989, The Journal of pediatrics.

[25]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[26]  S. Wise,et al.  Acetaminophen prophylaxis of adverse reactions following vaccination of infants with diphtheria-pertussis-tetanus toxoids-polio vaccine. , 1987, The Pediatric infectious disease journal.

[27]  O. Snead,et al.  Neurologic complications of immunizations. , 1986, The Journal of pediatrics.

[28]  E. Scolnick,et al.  Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. , 1986, The Journal of infection.

[29]  M. Myers,et al.  Primary immunization with tetanus and diphtheria toxoids. Reaction rates and immunogenicity in older children and adults. , 1982, JAMA.

[30]  J. Cherry,et al.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. , 1981, Pediatrics.

[31]  G. Beebe,et al.  Long-term mortality follow-up of Army recruits who received adjuvant influenza virus vaccine in 1951-1953. , 1972, American journal of epidemiology.

[32]  G. Edsall,et al.  Combined tetanus-diphtheria immunization of adults: use of small doses of diphtheria toxoid. , 1954, American journal of public health and the nation's health.